ExploreWatchlistsPricing
  1. JP-listed companies
  2. MEDIPAL HOLDINGS CORPORATION
  3. Financials
  4. EBITDA

MEDIPAL HOLDINGS CORPORATION (7459)

Market cap
¥634.2B
P/E ratio
17.3x
Medipal Holdings distributes pharmaceuticals, medical devices, cosmetics, daily necessities, and veterinary products through 34 subsidiaries across Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 202572,725+13.17%
Mar 31, 202464,261+1.41%
Mar 31, 202363,365+6.13%
Mar 31, 202259,707+12.56%
Mar 31, 202153,044-21.23%
Mar 31, 202067,341+6.42%
Mar 31, 201963,279+6.97%
Mar 31, 201859,158+11.15%
Mar 31, 201753,223-2.65%
Mar 31, 201654,674+21.17%
Mar 31, 201545,120

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat